U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
CADONILIMAB
INN   USAN  
Official Name English
AK-104
Preferred Name English
PD-1 X CTLA-4 DUAL CHECKPOINT INHIBITOR AK104
Common Name English
CADONILIMAB [USAN]
Common Name English
cadonilimab [INN]
Common Name English
IMMUNOGLOBULIN G1-KAPPA ANTI-(HOMO SAPIENS PDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), EACH HEAVY CHAIN BEING FUSED TO A SCFV ANTI- (HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152)), MONOCLONAL ANTIBODY, BISPECIFIC, TETRAV
Common Name English
ANTI-PD1/ANTI-CTLA4 BISPECIFIC ANTIBODY AK104
Common Name English
IMMUNOGLOBULIN G1 (235-ALANINE,236-ALANINE,238-ALANINE), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGS)4 FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASS
Common Name English
Cadonilimab [WHO-DD]
Common Name English
AK104
Code English
Code System Code Type Description
FDA UNII
6FYG1DS4NW
Created by admin on Wed Apr 02 02:37:01 GMT 2025 , Edited by admin on Wed Apr 02 02:37:01 GMT 2025
PRIMARY
CAS
2233593-44-5
Created by admin on Wed Apr 02 02:37:01 GMT 2025 , Edited by admin on Wed Apr 02 02:37:01 GMT 2025
NO STRUCTURE GIVEN
NCI_THESAURUS
C153379
Created by admin on Wed Apr 02 02:37:01 GMT 2025 , Edited by admin on Wed Apr 02 02:37:01 GMT 2025
PRIMARY NCIT
CAS
2394841-59-7
Created by admin on Wed Apr 02 02:37:01 GMT 2025 , Edited by admin on Wed Apr 02 02:37:01 GMT 2025
PRIMARY
SMS_ID
300000038020
Created by admin on Wed Apr 02 02:37:01 GMT 2025 , Edited by admin on Wed Apr 02 02:37:01 GMT 2025
PRIMARY
USAN
JK-159
Created by admin on Wed Apr 02 02:37:01 GMT 2025 , Edited by admin on Wed Apr 02 02:37:01 GMT 2025
PRIMARY
INN
11581
Created by admin on Wed Apr 02 02:37:01 GMT 2025 , Edited by admin on Wed Apr 02 02:37:01 GMT 2025
PRIMARY INN
ACTIVE MOIETY
CADONILIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966